US EditionPrice T Rowe Associates Inc. MD Boosts Stock Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT)
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Price T Rowe Associates Inc. MD Boosts Stock Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT)
Price T Rowe Associates Inc. MD increased its position in Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) by 3.4% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 54,753 shares of the biotechnology company’s stock after acquiring an additional 1,825 shares during […]
Price T Rowe Associates Inc. MD Purchases 1,825 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT)
Price T Rowe Associates Inc. MD raised its position in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) by 3.4% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 54,753 shares of the biotechnology company’s stock after purchasing an additional 1,825 shares during the quarter. Price T Rowe Associates Inc. MD’s holdings in […]
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
